A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.
Experimental Treatment Gaining Traction Online
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Followers are encouraged to message these accounts directly for source information, while also receiving promotional offers.
Active Commerce on Social Networks
Separately, a flourishing market exists on Telegram, where communities with numerous of members share “before and after” images, administration instructions and claims of rapid British shipping. Sellers market the drug there before directing buyers to other platforms for purchases.
Learning About Retatrutide
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Professionals Voice Worries
Nevertheless, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could result in users administering products of unknown origin.
Several experts stated the demand for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, risking penalties, legal action or prison.
Service Reaction and Material Elimination
Based on TikTok, the service has taken down problematic content and banned associated hashtags and query recommendations. The company said it was committed to keeping the service secure and investing in strengthening compliance measures.
Digital Marketplace Activities
Research also discovered communities with up to 9,000 members marketing the experimental drug using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, populated with images of slimming results, positive reviews and step-by-step guides for mixing or injecting at home.
Within moments of joining one community, a vendor shared WhatsApp details, where most transactions occur. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.
Product Information and Costs
Inside these communities, messages show black plastic parcels with postal service labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When questioned how much time a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram said it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering materials they can’t verify. Although the research behind this drug is sound, these digital products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.
Her staff has already encountered individuals injured by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental product not yet authorized … may expose patients to potentially serious medical dangers”.
